Zobrazeno 1 - 10
of 252
pro vyhledávání: '"C. M. Kirsch"'
Publikováno v:
Nuklearmedizin. 50:53-67
SummaryAim: To explain the spectrum and number of in-vivo nuclear medicine examinations and therapies based on official statistics about out-patient and in-patient care. Trends in time of the frequency and spectrum of procedures as well as data on th
Autor:
Aleksandar Grgic, Ursula Nestle, J. Schubert, J. Pinkert, C. Puskas, L. Truemper, J. König, D. Hellwig, C.-M. Kirsch, E. Ballek, Klemens Scheidhauer, K. Hohloch
Publikováno v:
Nuklearmedizin. 50:39-47
Summary Aim: Although predictive factors (PF) for conventional lymphoma therapy are established and frequently used in clinical practice and medical research, the PF for radioimmunotherapy (RIT) have not been fully defined until now. The aim of this
Autor:
Michail Plotkin, Joerg Pinkert, Lilli Geworski, C. M. Kirsch, Andrea Schaefer, Bernd O. Knoop
Publikováno v:
Nuklearmedizin. 49:85-95
SummaryIn nuclear medicine therapy the treatment of tumours by radiation exposure from internally deposited labelled antibodies or labelled peptides is currently an active field of investigation. To permit the efficient delivery of high amounts of ra
Publikováno v:
Nuklearmedizin. 48:59-69
Summary Aim: Currently, the German and Austrian S3 guidelines on the evaluation and treatment of lung cancer are about to be published whereas the American Colleague of Chest Physicians (ACCP) guidelines were already presented in 2007. An important p
Autor:
C.-M. Kirsch, D. Hellwig
Publikováno v:
Der Nuklearmediziner. 31:321-327
AIM: 18 F-FDG PET is the most accurate noninvasive modality for staging mediastinal lymph nodes in lung cancer. Beside using visual image interpretation, some institutions use standardized uptake value (SUV) measurements in lymph nodes. Mostly, an SU
Publikováno v:
Nuklearmedizin. 42:135-144
Summary: Aims: To evaluate studies on the use of positron emission tomography with the glucose analog 18F-fluorodeoxyglucose (FDG-PET) for the preoperative staging of patients with non-small cell lung cancer (NSCLC) according to the criteria of evide
Publikováno v:
Nuklearmedizin. 41:217-220
ZusammenfassungZiel: Die FDG-PET-Untersuchung hat in den vergangenen Jahren bei onkologischen Fragestellungen insbesondere beim Staging des Bronchialkarzinoms wachsende Bedeutung erlangt. In der vorliegenden retrospektiven Untersuchung wurde der Einf
Autor:
C.-M. Kirsch
Publikováno v:
Der Nuklearmediziner. 25:256-262
Publikováno v:
Nuklearmedizin. 39:204-208
Summary Aim: The aim of the study was the determination of the radiation exposure to the patient caused by singlephoton transmission mesasurement for 3D whole-body PET. Material and Method: Single-photon-transmission measurement is performed using tw
Autor:
C. M. Kirsch, S. Samnick
Publikováno v:
Nuklearmedizin. 38:292-296
Zusammenfassung Ziel: Meta-Iodbenzylguanidin (I-123/I-131-MIBG) wird derzeit mit niedriger spezifischer Aktivität in der Erfassung neuroadrenerger Funktionsstörungen des Herzen sowie im Management neuroendokriner Tumoren eingesetzt. Jedoch wird int